Acute myeloid leukemia (AML) cells treated with IFN-γ showed increased HLA-E surface expression, which impaired CD94/NKG2A-dependent NK cell-mediated cytolysis [152]. This evidence concerns the gene IFNG and acute myeloid leukemia.